The mouse trap

Author： Persson C.G.A.   Erjefalt J.S.   Korsgren M.   Sundler F.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.18, Iss.12, 1997-12, pp. : 465-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aflibercept: AVE 0005, AVE 005, AVE0005, VEGF Trap - Regeneron, VEGF Trap (R1R2), VEGF Trap-Eye

By Adis International Limited  

Drugs in R&D, Vol. 9, Iss. 4, 2008-01 ,pp. : 261-269

Adis International

Access to resources Recommend Favorite

Clopidogrel affects TRAP, ADP effects in ACS

By  

Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 6, 2011-12 ,pp. : 497-508

Bentham Science Publishers

Access to resources Recommend Favorite

Atypical Chest Pain in ACS: A Trap Especially for Women

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3877-3884

Bentham Science Publishers

Access to resources Recommend Favorite

Corticotropin-Releasing Factor Binding Protein - A Ligand Trap?

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-10 ,pp. : 953-960

Bentham Science Publishers

Access to resources Recommend Favorite